CD34 and Alzheimer disease: Nevertheless, our study sheds some light for increasing circulating CD34+CD133+ endothelial progenitors to reduce AD risk, especially among those individuals with vascular diseases and the vulnerable KIRREL3 and EXOC6B genotypes.